Effect of decarboxylase inhibitors on brain p-tyrosine levels
- 1 April 1987
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 36 (8) , 1373-1376
- https://doi.org/10.1016/0006-2952(87)90097-9
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Inhibition of Aromatic L‐Amino Acid Decarboxylase and Tyrosine Aminotransferase by the Monoamine Oxidase Inhibitor PhenelzineJournal of Neurochemistry, 1986
- Catecholamine synthesis: Physiological coupling to precursor supplyBiochemical Pharmacology, 1986
- Partial lesions of the nigrostriatal pathway in the rat Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugsNeuropharmacology, 1985
- Decarboxylation of p‐Tyrosine: A Potential Source of p‐Tyramine in Mammalian TissuesJournal of Neurochemistry, 1983
- The biosynthesis of p‐tyramine, m‐tyramine, and β‐phenylethylamine by rat striatal slicesJournal of Neuroscience Research, 1983
- Adaptation of the liquid cation exchange method for the assay of 3,4-dihydroxy-L-phenylalanine and 5-hydroxy-L-tryptophan decarboxylases in rat brainBrain Research, 1976
- Decarboxylation to tyramine is not a major route of tyrosine metabolism in mammalsArchives of Biochemistry and Biophysics, 1976
- AN EXAMINATION OF THE CATALYTIC PROPERTIES OF SEVERAL AMINOTRANSFERASES IN BRAIN AND LIVER BY MEANS OF AN IMPROVED RADIOMETRIC ASSAY WITH DINITROPHENYLHYDRAZINEJournal of Neurochemistry, 1975
- Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugsLife Sciences, 1974
- A sensitive and specific isotopic assay for the estimation of tyrosine transaminaseBiochemical Pharmacology, 1968